569
Views
9
CrossRef citations to date
0
Altmetric
Original Article

The cost implications of first anniversary renal function after living, standard criteria deceased and expanded criteria deceased donor kidney transplantation

, , , &
Pages 75-84 | Accepted 09 Aug 2012, Published online: 25 Sep 2012

References

  • Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305
  • Smith DH, Gullion CM, Nichols G, et al. Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population. J Am Soc Nephrol 2004;15:1300-6
  • Lentine KL, Xiao H, Machnicki G, et al. Renal function and healthcare costs in patients with polycystic kidney disease. Clin J Am Soc Nephrol 2010;5:1471.
  • Gill JS, Tonelli M, Mix CH, et al. The change in allograft function among long-term kidney transplant recipients. J Am Soc Nephrol 2003;14:1636-42
  • Schnitzler MA, Whiting JF, Brennan DC, et al. The expanded criteria donor dilemma in cadaveric renal transplantation. Transplantation 2003;75:1940-5
  • Schnitzler MA, Johnston K, Axelrod D, et al. Associations of renal function at 1-year after kidney transplantation with subsequent return to dialysis, mortality, and healthcare costs. Transplantation 2011;91:1347-56
  • United States Renal Data System. Researcher's Guide to the United States Renal Data System Database, 2010. Available at: http://www.usrds.org/2010/rg/fb/index.html. Accessed July 7, 2012
  • Whiting JF, Woodward RS, Zavala EY, et al. Economic cost of expanded criteria donors in cadaveric renal transplantation: analysis of Medicare payments. [see comment]. Transplantation 2000;70:755-60
  • United Network for Organ Sharing (UNOS) UNOS Policy 3.5.1 Definition of Expanded Criteria Donor and Standard Donor. [cited December 4, 2007]. http://optn.transplant.hrsa.gov/PoliciesandBylaws2/policies/pdfs/policy_7.pdf. Accessed July 7, 2012
  • Levey AS, Greene T, Kusek JW, et al. A simplified equation to prediction glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000;11:155A
  • Poggio ED, Wang X, Weinstein DM, et al. Assessing glomerular filtration rate by estimation equations in kidney transplant recipients. Am J Transplant 2006;6:100-8
  • Gheorghian A, Schnitzler MA, Axelrod D, et al. The implications of acute rejection and reduced allograft function on health care expenditures in contemporary US kidney transplantation. Transplantation 2012;94:241-9
  • Lentine KL, Gheorghian A, Axelrod D, et al. The implications of acute rejection for allograft survival in contemporary U.S. kidney transplantation. Transplantation 2012;94(4):369-76
  • Bureau of Labor Statistics. Consumer Price Index 2003, US Average Medical Care. http://data.bls.gov/PDQ/servlet/SurveyOutputServlet. Accessed July 11, 2011
  • Schoenberg IJ. Contributions to the problem of approximation of equidistant data by analytic functions. Quart Appl Math 1946;4:45-99, 112-41
  • Ruppert D, Wand MP, Carroll RJ. Semiparametric Regression. Cambridge: Cambridge Series in Statistical and Probabilistic Mathematics. 2003
  • Wolfe RA, McCullough KP, Schaubel DE, et al. Calculating life years from transplant (LYFT): methods for kidney and kidney-pancreas candidates. Am J Transplant 2008;8:997-1011
  • Sinha R, Saad A, Marks SD. Prevalence and complications of chronic kidney disease in paediatric renal transplantation: a K/DOQI perspective. Nephrol Dial Transplant 2010;25:1313-20
  • Costa de Oliveira CM, Mota MU, Mota RS, et al. Prevalence and staging of chronic kidney disease in renal transplant recipients. Clin Transplant 2009;23:628-36
  • Jimenez Alvaro S, Marcen R, Teruel JL, et al. Management of chronic kidney disease after renal transplantation: is it different from nontransplant patients? Transplant Proc 2009;41:2409-11
  • Lefebvre P, Duh MS, Buteau S, et al. Medical costs of untreated anemia in elderly patients with predialysis chronic kidney disease. J Am Soc Nephrol 2006;17:3497-502
  • St Peter WL, Khan SS, Ebben JP, et al. Chronic kidney disease: the distribution of health care dollars. Kidney Int 2004;66:313-21
  • Trivedi H. Cost implications of caring for chronic kidney disease: are interventions cost-effective? Adv Chronic Kidney Dis 2010;17:265-70
  • Magee JC, Barr ML, Basadonna GP, et al. Repeat organ transplantation in the United States, 1996–2005. Am J Transplant 2007;7:1424-33
  • Vincenti F, Larsen C, Durrbach A, et al. Costimulation blockade with belatacept in renal transplantation. N Engl J Med 2005;353:770-81
  • Schnitzler MA, Lentine KL, Gheorghian A, et al. Renal function following living, standard criteria deceased and expanded criteria deceased donor kidney transplantation: impact on graft failure and death. Transpl Int 2012;25:179-91
  • Schnitzler MA, Lentine KL, Axelrod D, et al. Use of 12-month renal function and baseline clinical factors to predict long-term graft survival: application to BENEFIT and BENEFIT-EXT trials. Transplantation 2012;93:172-81
  • Woodward RS, Schnitzler MA, Baty J, et al. Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant 2003;3:590-8
  • Buchanan PM, Lentine KL, Burroughs TE, et al. Association of lower costs of pulsatile machine perfusion in renal transplantation from expanded criteria donors. Am J Transplant 2008;8:2391-401

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.